Estrogens and neuropeptides in Raynaud's phenomenon

Rheumatic Disease Clinics of North America

Volumn 31, Issue 1, 2005, Pages 177-186

  Generini, Sergio ^a   Seibold, James R ^b   Matucci Cerinic, Marco ^a  

^a Division of Medicine I   (Italy)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; HORMONE; NEUROKININ A; NEUROPEPTIDE; NEUROPEPTIDE Y; SEX HORMONE; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL TONE; BLOOD VISCOSITY; CELL INTERACTION; CHOLINERGIC SYSTEM; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ESTROGEN THERAPY; HUMAN; IMMUNE SYSTEM; MICROCIRCULATION; NERVE ENDING; NEUROTRANSMISSION; NOCICEPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REVIEW; SENSORY SYSTEM; SMOOTH MUSCLE FIBER; VASOCONSTRICTION; VASODILATATION; VASOMOTOR DISORDER;

ESTROGENS; HUMANS; NEUROPEPTIDES; RAYNAUD DISEASE; RECEPTORS, SENSORY; VASODILATION;

EID: 11444270569     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2004.10.005     Document Type: Review

References (49)

1. M. Raynaud De l'asphyxie locale et de la gangrène symétrique des extrémités. Thése de medicine [Local asphyxiation and symmetrical gangrene in the limbs. Thesis in medicine] 1862 Rigoux Ed Paris [in French]
2. S. Guiducci, A. Pignone, and M. Matucci Cerinic Raynaud's phenomenon D. Furst P. Clements Systemic sclerosis 2004 Lippincott Williams & Wilkins Philadelphia 221 239
3. F. Wigley Clinical practice. Raynaud's phenomenon N Engl J Med 347 2002 1001 1008
4. H.R. Maricq, M.C. Weinrich, and J.E. Keil Prevalence of Raynaud's phenomenon in the general population. A preliminary study by questionnaire J Chron Dis 39 1986 423 426
5. M. Matucci Cerinic Sensory neuropeptides and rheumatic diseases Rheum Dis Clin N Am 19 1993 975 982
6. B.M. Kahaleh, and M. Matucci Cerinic Raynaud's phenomenon. Dysregulated neuroendothelial control of vascular tone Arthritis Rheum 38 1995 1 4
7. F.M. Wigley, and N.A. Flavahan Raynaud's phenomenon Rheum Dis Clin North Am 22 1996 765 781
8. D.G. Harrison, and H. Cai Endothelial control of vasomotion and nitric oxide production Cadiol Clin 21 2003 289 302
9. V. Ralevic, and G. Burnstock Neural endothelial interactions in the control of vascular tone 1993 Landes Publishing Co. Houston (TX)
10. M.L. Bartelink, H. Wollersheim, and H. Vemer The effects of single oral doses of 17 beta estradiol and progesterone on finger skin circulation in healthy women and in women with primary Raynaud's phenomenon Eur J Clin Pharmacol 46 1994 557 560
11. K. Hishikawa, T. Nakaki, and T. Marumo Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells FEBS Lett 360 1995 291 293
12. H.P. Kim, J.Y. Lee, and J.K. Jeong Non genomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alfa localized in caveolae Biochem Biophys Res Commun 263 1999 257 262
13. Y. Zhang, K.G. Stewart, and S.T. Davidge Endogenous estrogen mediates vascular reactivity and distensibility in pregnant rat mesenteric arteries Am J Physiol Heart Circ Physiol 280 2001 956 961
14. A. Mugge, M. Riedel, and M. Barton Endothelium independent relaxation of human coronary arteries by 17 beta estradiol in vitro Cardiovasc Res 27 1993 1939 1942
15. H. Momoi, F. Ikomi, and T. Ohhashi Estrogen induced augmentation of endothelium dependent nitric oxide mediated vasodilation in isolated rat cerebral arteries Jpn J Physiol 53 2003 193 203
16. A. Huang, D. Sun, and Z. Wu estrogen elicits cytochrome p450 mediated flow induced dilation of arterioles in NO deficiency: role of P13K-Akt phosphorylation in genomic regulation Circ Res 94 2004 245 252
17. H. Jokela, P. Dastidar, and R. Rontu Effects of long term estrogen replacement therapy versus combined hormone replacement therapy on nitric oxide dependent vasomotor function J Clin Endocrinol Metab 88 2003 4348 4354
18. R. Lew, P. Komesaroff, and M. Williams Endogenous estrogens influence endothelial function in young men Circ Res 93 2003 1127 1133
19. S. Girdler, A.L. Hinderliter, and E.C. Wells Transdermal vs oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effects Obstet Gynecol 103 2004 169 180
20. E.H. Lieberman, M.D. Gerhard, and A. Uehata Estrogen improves endothelium dependent flow mediated vasodilation in postmenopausal women Ann Int Med 121 1994 936 941
21. U. Lang, R. Baker, and K. Clarke Estrogen induced increases in coronary blood flow are antagonized by inhibitors of nitric oxide synthesis Eur J Obstet Gynecol Reprod Biol 74 1997 229 235
22. J. Lekakis, M. Mavrikakis, and M. Emmanuel Acute estrogen administration can reverse cold induced coronary Raynaud's phenomenon in systemic sclerosis Clin Exp Rheumatol 14 1996 421 424
23. J. Lekakis, M. Mavrikakis, and M. Emmanuel Short term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon Am Heart J 136 1998 905 912
24. J. Lekakis, C. Papamichael, and M. Mavrikakis Effect of long term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud's phenomenon secondary to systemic sclerosis Am J Cardiol 82 1998 1555 1557
25. Ibba Manneschi L., Del Rosso A., Milia A.F., et al. Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis. Rheumatology, in press
26. A. Tottrup, and K. Kraglund Endothelium-dependent responses in small human mesenteric arteries Physiol Rev 53 2004 255 263
27. M.C. Mione, V. Ralevic, and G. Burnstock Peptides and vasomotor mechanisms Pharmacol Ther 46 1990 429 468
28. F. Lembeck, and P. Holzer Substance P as a neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation Naunyn Schmiedebergs Arch Pharmacol 310 1979 175 183
29. J. Bienenstock Evidence for mast cells nerve interactions E. Goetz Neuroimmune networks: physiology and diseases 1989 Alan R. Liss New York 275 310
30. P. Milner, P. Bodin, and A. del Rosso Regulation of substance P mRNA expression in human dermal microvascular endothelial cells in systemic sclerosis Clin Exp Rheumatol 22 Suppl 33 2004 s24 s29
31. R. Couture, and R. Kerouac Plasma extravasation induced by mammalian tachykinins in rat skin: influence of anesthetic agents and acetylcholine antagonist Br J Pharmacol 91 1987 265 273
32. V. Ralevic, Z. Khalil, and R.D. Helme Role of nitric oxide in the actions of substance P and other mediators of inflammation in rat skin microvasculature Eur J Pharmacol 25 1995 231 239
33. H. Shirahase, M. Kanda, and K. Kurahashi Endothelium dependent contraction in intrapulmonary arteries: mediation by endothelial NK1 receptors and TXA2 Br J Pharmacol 115 1995 1215 1220
34. M.C. Mione, V. Ralevic, and G. Burnstock Peptides and vasomotor mechanisms Pharamacol Ther 46 1990 429 468
35. J. Raud, T. Lundeberg, and G. Brodda Jansen Potent antiinflammatory action of calcitonin gene related peptide J Immunol 146 1995 3424
36. R. Chatila, L. Ferayorni, and T. Gupta Local arterial vasoconstriction induced by octreotide in patients with cirrhosis Hepatology 31 2000 572 576
37. J.K. McDonald NPY and related substances CRC Crit Rev Neurobiol 4 1988 97 107
38. F. Fabi, L. Argiolas, and G. Ruvolo NPY induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane Br J Pharmacol 124 1998 101 110
39. C.B. Bunker, G. Terenghi, and D.R. Springall Deficiency of calcitonin gene related peptide in Raynaud's phenomenon Lancet 336 1990 1530 1535
40. P.C. Goldsmith, F.A. Molina, and C.B. Bunker Cutaneous nerve fibre depletion in vibration white finger J R Soc Med 87 1994 377 381
41. C.B. Bunker, P.C. Goldsmith, and T.A. Leslie Calcitonin gene related peptide, endothelin 1, the cutaneous microvasculature and Raynaud's phenomenon Br J Dermatol 134 1996 399 406
42. A. Wallengren, A. Akesson, and A. Scheja Occurrence and distribution of peptidergic fibers in skin biopsies from patients with systemic sclerosis Acta Derm Venereol 76 1996 126 128
43. A. Akesson, and R. Ekman Gastrointestinal regulatory peptides in systemic sclerosis Arthritis Rheum 36 1993 698 703
44. R. Casale, S. Generini, and F. Luppi Raynaud's phenomenon, increased sympathetic postganglionic activity and alveolitis in systemic sclerosis. Potential reversal by cyclophosphamide Arthritis Care Res (Arthritis Rheum) 51 2004 665 669
45. S. Lori, M. Matucci Cerinic, and R. Casale Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure Clin Exp Rheumatol 14 1996 601 605
46. A.R. Rubio, and M.A. Morales-Segura Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control Arch Med Res 35 2004 1 11
47. P. Milner, V. Ralevic, and A.M. Hopwood Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia Experientia 45 1989 121 125
48. P. Milner, K. Kirpatrick, and V. Ralevic Endothelial cells cultured from human umbilical vein release ATP substance P and acetylcholine in response to increased flow Proc R Soc Lond B Biol Sci 241 1990 245 248
49. S.P. Spencer, P. Milner, and P. Bodin Modulation of endothelin release by vasoactive peptides localised in human umbilical vein endothelial cells Endothelium 4 1996 309 317